{"document_type": "article", "snippet": "The turmoil in Valeant Pharmaceuticals International shares reveals a dangerous tendency of hedge funds to engage in herd behavior when investing.", "type_of_material": "News", "web_url": "http://www.nytimes.com/2015/10/28/business/dealbook/valeant-stock-plunge-shows-risk-of-following-the-leader.html", "subsection_name": "DealBook", "blog": [], "section_name": "Business Day", "source": "The New York Times", "pub_date": "2015-10-28T00:00:00Z", "word_count": "1180", "slideshow_credits": null, "news_desk": "Business", "byline": {"original": "By STEVEN DAVIDOFF SOLOMON", "person": [{"firstname": "Steven", "middlename": "Davidoff", "organization": "", "role": "reported", "lastname": "SOLOMON", "rank": 1}]}, "abstract": "Steven Davidoff Solomon Deal Professor column points out sudden reversal in fortunes for Valeant Pharmaceuticals International underscores how hedge funds can sometimes participate in herd behavior, to detrimental results; notes Valeant was once darling of hedge funds, but suffered sharp drop in its stock price due to concerns about its practices; suggests that incident raises questions about what services hedge funds actually provide.", "keywords": [{"value": "Hedge Funds", "rank": "1", "name": "subject", "is_major": "Y"}, {"value": "Valeant Pharmaceuticals International Inc", "rank": "2", "name": "organizations", "is_major": "Y"}, {"value": "ValueAct Capital Partners", "rank": "3", "name": "organizations", "is_major": "N"}, {"value": "Pearson, John Michael (1959- )", "rank": "4", "name": "persons", "is_major": "N"}, {"value": "Morfit, G Mason", "rank": "5", "name": "persons", "is_major": "N"}], "print_page": "8", "multimedia": [{"subtype": "wide", "legacy": {"wideheight": "126", "wide": "images/2015/10/28/business/28dealprofillo-web/28dealprofillo-web-thumbWide-v2.jpg", "widewidth": "190"}, "type": "image", "width": 190, "height": 126, "url": "images/2015/10/28/business/28dealprofillo-web/28dealprofillo-web-thumbWide-v2.jpg"}, {"subtype": "xlarge", "legacy": {"xlargeheight": "599", "xlargewidth": "600", "xlarge": "images/2015/10/28/business/28dealprofillo-web/28dealprofillo-web-articleLarge.jpg"}, "type": "image", "width": 600, "height": 599, "url": "images/2015/10/28/business/28dealprofillo-web/28dealprofillo-web-articleLarge.jpg"}, {"subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/10/28/business/28dealprofillo-web/28dealprofillo-web-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "type": "image", "width": 75, "height": 75, "url": "images/2015/10/28/business/28dealprofillo-web/28dealprofillo-web-thumbStandard.jpg"}], "lead_paragraph": "The turmoil in Valeant Pharmaceuticals International shares reveals a dangerous tendency of hedge funds to engage in herd behavior when investing.", "headline": {"kicker": "Deal Professor", "content_kicker": "Deal Professor", "print_headline": "Valeant Stock Plunge Shows the Risk of Following the Leader", "main": "Valeant Stock Plunge Shows the Risk of Following the Leader"}, "_id": "562fbfb338f0d8595b45ca11"}